CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,234 | -27.3% | 2,511 | -2.0% | 0.09% | -23.8% |
| Q2 2023 | $348,150 | +27.1% | 2,562 | -2.9% | 0.12% | +23.2% |
| Q1 2023 | $273,983 | -23.1% | 2,638 | -34.3% | 0.10% | -27.2% |
| Q4 2022 | $356,156 | -23.9% | 4,018 | -31.2% | 0.14% | -33.7% |
| Q3 2022 | $468,000 | -17.6% | 5,841 | -1.6% | 0.20% | -10.9% |
| Q2 2022 | $568,000 | -33.9% | 5,933 | +2.6% | 0.23% | -24.8% |
| Q1 2022 | $859,000 | +9.8% | 5,780 | +4.8% | 0.31% | +15.5% |
| Q4 2021 | $782,000 | +12.5% | 5,514 | +3.8% | 0.26% | -16.7% |
| Q3 2021 | $695,000 | -4.7% | 5,313 | +0.2% | 0.32% | -1.9% |
| Q2 2021 | $729,000 | -2.3% | 5,305 | -7.1% | 0.32% | -5.8% |
| Q1 2021 | $746,000 | +18.8% | 5,713 | +1.8% | 0.34% | +8.9% |
| Q4 2020 | $628,000 | – | 5,611 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |